Add v64otd.com to your daily reading list — the ledger doesn't lie.
On January 25, 2026 — five months ago — two researchers employed by the National Institutes of Health arrived at Detroit Metropolitan Airport carrying a large black plastic case after nine days in Brazzaville, Republic of Congo, where a significant monkeypox outbreak was underway. They had flown via Paris. When US Customs and Border Protection officers asked what was in the case, both men said it contained diagnostics and testing equipment. It did not. It contained 113 vials packed in Styrofoam coolers. Of the first 20 vials tested by the FBI, 17 contained deactivated monkeypox virus. One contained chickenpox virus. Two contained human DNA. The men were allowed to continue to their destination. Federal charges were filed Tuesday, June 2. The criminal complaint was unsealed Wednesday. They appeared in federal court in Missoula, Montana on Wednesday afternoon.
The senior researcher is Vincent Munster, 53, a Dutch citizen and Chief of the Virus Ecology Section at NIH's Rocky Mountain Laboratories in Hamilton, Montana — a Biosafety Level 4 facility, the highest biosafety designation that exists, reserved for research involving the most dangerous known and potential human pathogens on earth. His research focus, per the DOJ's own criminal complaint, is "emerging viral pathogens" and how those pathogens "cross the species barrier." The junior researcher is Claude Kwe, 38, a citizen of Cameroon and a research fellow in Munster's section. Both are charged with conspiracy to smuggle biological materials into the United States and making false statements to federal investigators. Both face a maximum sentence of five years in prison.
That is the charge. What surrounds the charge — the research history of the man accused, the facility he works in, the pathogens his lab keeps, and the professional network he has operated in for over a decade — is the story the mainstream press is not fully telling.
Who Vincent Munster Is — And Why His Name Should Ring a Bell
Vincent Munster is not an obscure researcher. He is one of the most prominent virologists studying bat-borne emerging pathogens in the world — and his professional network reads like a who's who of the institutions and individuals at the center of every major biosafety controversy of the last decade.
Munster received his PhD in virology from Erasmus University Rotterdam, where he studied under Ab Osterhaus and Ron Fouchier — the Dutch virologist who in 2011 created a genetically modified version of H5N1 bird flu that was airborne transmissible between ferrets, triggering one of the most significant scientific controversies in the history of gain-of-function research. Fouchier's work was so alarming that the US National Science Advisory Board for Biosecurity asked the journals Science and Nature to suppress the publication of the full methodology — an unprecedented request that was ultimately partially reversed after revisions. Munster trained under him.
Munster joined Rocky Mountain Laboratories in 2009. His lab's work, per his own published research and FOIA documents obtained by the US Right to Know watchdog, includes maintaining animal colonies of Egyptian fruit bats — a species studied as a potential reservoir host for SARS-CoV-2 — Syrian hamsters, deer mice, and other species used in disease transmission research. His laboratory houses all five SARS-CoV-2 transmission models. In 2018, he won two DARPA PREEMPT projects involving self-spreading bat vaccine technology — a highly controversial research approach in which a vaccine is engineered to spread through animal populations without requiring individual administration.
In 2018, Munster was a co-author on the DEFUSE proposal — the rejected DARPA blueprint for engineering bat coronaviruses that multiple scientists and biosafety researchers have noted bore an unsettling resemblance to the properties of SARS-CoV-2. That same year, he was the lead author on an experiment that infected bats with a Chinese bat coronavirus strain originally collected by Peter Daszak of EcoHealth Alliance and Shi Zhengli of the Wuhan Institute of Virology. In December 2018, Munster also co-published a separate Egyptian fruit bat infection study with Ralph Baric — the University of North Carolina virologist who collaborated with the Wuhan Institute of Virology on bat coronavirus research funded through EcoHealth Alliance.
These are not casual professional connections. They are documented research collaborations — on the DEFUSE proposal, on bat infection experiments using Wuhan-collected viral strains, on DARPA-funded self-spreading vaccine technology — between the man now charged with smuggling viral material through US customs and the central figures of the most consequential biosafety debate in modern history. FOIA documents obtained by US Right to Know and published in peer-reviewed context include email exchanges among Munster and Shi Zhengli regarding bat colony research. The animal testing watchdog White Coat Waste, which has flagged Munster's federally funded primate and bat research for taxpayer, biosafety, and national security concerns for years, highlighted the charges immediately after they were unsealed Tuesday and has previously called on Congress and RFK Jr. to defund and decommission Rocky Mountain Laboratories entirely.
What Was in the Case — And What the Law Required
The legal framework governing the import of biological materials into the United States is not ambiguous. Under 42 USC 264 and implementing CDC regulations, the importation of any biological agent — including deactivated viral samples — requires prior authorization from the CDC. Researchers are required to declare biological materials at customs. Failure to declare is itself a federal violation. Lying to federal investigators — which both men are charged with doing — is a separate federal offense.
Munster's professional role is relevant here. As Chief of the Virus Ecology Section at a BSL-4 NIH facility, he is not a graduate student unfamiliar with biosafety protocols. He is the senior researcher in charge of the section. He has spent his career working with dangerous pathogens under the highest biosafety protocols in existence. The DOJ's complaint states he "adamantly denied" returning with biological materials when CBP officers questioned him directly. That denial — made at the airport, before any legal proceedings — is the false statement charge.
The deactivated nature of the virus is being cited by some outlets as a mitigating factor. It deserves precise treatment. Deactivated virus has been chemically or thermally treated to eliminate its ability to replicate. It cannot cause infection in the way live virus can. The WHO and CDC use deactivated viral samples routinely in diagnostics and research. However: deactivated status does not eliminate import declaration requirements. It does not eliminate the requirement for prior CDC authorization. It does not explain why a senior BSL-4 researcher told customs officers the case contained only testing equipment when it contained 113 vials of any biological material. The deactivated nature of the samples may affect sentencing. It does not explain the lie.
The Rocky Mountain Laboratory — And What It Keeps
Rocky Mountain Laboratories in Hamilton, Montana is a federally operated NIH facility that has been conducting research on dangerous pathogens since 1928. It is one of only a handful of BSL-4 facilities in the country cleared to work with the most dangerous pathogens known to science — including Ebola, Marburg, and other viral hemorrhagic fevers alongside the emerging pathogen research Munster's section specializes in.
Munster's own lab, per FOIA documents, maintains colonies of Egyptian fruit bats, Syrian golden hamsters, and deer mice — species that serve as animal models for studying how bat-origin viruses cross the species barrier into human hosts. He keeps all five SARS-CoV-2 transmission models in his BSL-4 facility. His 2020 research on aerosolized SARS-CoV-2 — conducted at Rocky Mountain Labs in the early months of the pandemic — helped establish that the virus could remain viable in aerosol form for up to three hours. That research was cited by CDC officials during the public debate over airborne transmission, and Munster himself told the Washington Post in April 2020 that airborne transmission was "plausible" — a statement that contributed to months of public health confusion about how the virus spread.
The institution now finds its Chief of Virus Ecology charged with smuggling biological materials through US customs and lying to federal investigators about it. The NIH has acknowledged the investigation and stated it is cooperating with law enforcement. It has declined to provide further comment.
The Pattern That This Dispatch Has Been Documenting
V64OTD published a detailed gain-of-function dispatch in May examining the documented web of federally funded biological research, the COVID lab leak confirmation, the EcoHealth Alliance DOJ grand jury, and the Trump executive order pausing gain-of-function funding. That dispatch identified the structural problem at the heart of American biosafety: research institutions and individual researchers who operate in the gaps between oversight frameworks, funded by federal dollars, conducting research on pathogens capable of pandemic-scale harm, with accountability mechanisms that activate after problems occur rather than preventing them.
Vincent Munster is not the same as Peter Daszak of EcoHealth Alliance. His smuggling charges do not allege gain-of-function research violations or deliberate bioweapons development. The deactivated status of the samples he allegedly smuggled is a meaningful distinction from live pathogen smuggling. Those distinctions matter and they are stated here clearly. What also matters is the pattern: a senior federally funded BSL-4 researcher who co-authored the DEFUSE proposal, who ran experiments using Wuhan Institute of Virology-collected viral strains, who holds DARPA contracts for self-spreading bat vaccine technology, and whose lab keeps all five SARS-CoV-2 transmission models — arrived at a US airport carrying 113 undeclared vials of viral material and lied about it to federal officers. Five months passed before charges were filed. The incident occurred in January. The charges were unsealed in June.
The HHS Inspector General stated directly: "Any deliberate effort to conceal and smuggle biological materials into the United States without proper authorization is a breach of the public's trust and could have placed the public at risk." That statement is about deactivated virus. It is also a description of a pattern. The breach of public trust is the charge. The oversight failure is the context.
Call to Action: The Oversight Architecture Needs to Answer for This
The same federal apparatus that paused gain-of-function funding in May 2025, that confirmed COVID came from a Wuhan lab, that opened a grand jury into EcoHealth Alliance, and that is now prosecuting two NIH researchers for smuggling viral material — is the same apparatus that funded Munster's bat research for 17 years, cleared his professional collaborations with Shi Zhengli, Daszak, and Baric, and authorized the self-spreading bat vaccine DARPA projects operating inside his BSL-4 facility. The oversight failure is not new. The charges are.
Demand your congressional representative ask four specific questions on the record. First: how many other BSL-3 and BSL-4 researchers at federally funded facilities have returned from international fieldwork in high-risk outbreak zones in the last five years without declaring biological samples, and what is the CDC's detection rate for such violations? Second: what is the current status of the DARPA-funded self-spreading bat vaccine projects operating in Munster's section, and are those projects paused pending the outcome of the criminal case? Third: what review is the NIH conducting of Munster's section's research inventory, animal colonies, and sample handling protocols? Fourth: given that this incident occurred on January 25 and charges were not filed until June 2, what caused the five-month gap between the airport incident and the criminal complaint — and were any samples from the 113 vials used in NIH research during that interval?
These are not hostile questions. They are the minimum due diligence that the public — which funds both the NIH and the BSL-4 facilities operating in its name — is entitled to demand from the institutions responsible for their safety.
The 113 vials are in federal custody. The researchers are charged. The facility is still operating. The research network that produced this moment is still largely intact. The oversight apparatus that was supposed to prevent this is the same one that funded it. The ledger is open.
V64OTD // 113 VIALS. ONE LIE. FIVE MONTHS OF SILENCE. YOUR TAX DOLLARS FUNDED THE LAB